CDKN2A and glioblastoma: New insights into the genomic landscape of GBM revealed typical mutations in an array of genes, including TERT, PTEN, IDH1, IDH2, TP53, ATRX, PIK3CA, PIK3R1, NF1, H3F3A, CDKN2A, EGFR, PDGFRA, MET, CDK4, CDK6, MDM2, MDM4 [2].